Clinical Research

The physicians and clinical research coordinators at Capital Allergy & Respiratory Disease Center have a strong commitment to clinical research. We have multiple ongoing clinical trials throughout the year.

If you are interested in participating in one of our studies, please feel free to call or e-mail our clinical research department for further information.  Learn More about Clinical Research

Clinical Research Department
Phone: 916-233-2628
E-Mail: research@capitalallergy.com

You may also submit your name to be considered for a study by filling out this online form

Patients who qualify for participation in these studies will be provided with free study medication, free study-related care, and possible monetary compensation.

Our current studies include:

COPD:

  • AIRWISE – A randomized 12 month clinical trial comparing Stiolto Respimat vs triple therapy in the reduction of COPD exacerbations in patients with COPD.

Asthma:

  • CHRONICLE Study – A longitudinal observational study of the characteristics, treatment patterns and health outcomes of individuals with severe asthma in the United States.

COVID-19 UPdate

FROM CAPITAL ALLERGY & RESPIRATORY DISEASE CENTER
Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.
LEARN MORE

For the week of March 23-27 – Capital Allergy and Respiratory Disease Center Clinics will operate only between the hours of 8-5.

Effective Monday March 23 – Our New Injection Hours for all clinics will be 9-4 (until further notice)

New Injection Hours

Effective Monday March 23, 2020
Monday 9:00-3:45
Tuesday 9:00-3:45 (Folsom Closed)
Wednesday 9:00-3:45(J Street Closed)
Thursday 9:00-3:45
Friday 9:00-3:45